FGFR3 contributes to intestinal crypt cell growth arrest

Journal of Cellular Physiology

Volumn 216, Issue 1, 2008, Pages 261-268

  Arnaud Dabernat, Sandrine ^a,b,c   Yadav, Deepak ^a   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 18; FIBROBLAST GROWTH FACTOR RECEPTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR 3 ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RECEPTOR ANTIBODY;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYPT CELL; ENZYME ACTIVATION; ENZYME REGULATION; GROWTH INHIBITION; IN VITRO STUDY; INTESTINE CRYPT; INTESTINE EPITHELIUM; INTESTINE VILLUS; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; WILD TYPE; ANIMAL; CELL SHAPE; CYTOLOGY; INTESTINE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; CELL DIFFERENTIATION; CELL SHAPE; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTORS; INTESTINES; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 44449172548     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21401     Document Type: Article

References (38)

1. Agazie YM, Movilla N, Ischenko I, Hayman MJ. 2003. The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3. Oncogene 22:6909-6918.
2. Aliaga JC, Deschenes C, Beaulieu JF, Calvo EL, Rivard N. 1999. Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells. Am J Physiol 277:G631-G641.
3. Arnaud-Dabernat S, Kritzik M, Kayali AG, Zhang YQ, Liu G, Ungles C, Sarvetnick N. 2007. FGFR3 is a negative regulator of the expansion of pancreatic epithelial cells. Diabetes 56:96-106.
4. Bens M, Bogdanova A, Cluzeaud F, Miquerol L, Kerneis S, Kraehenbuhl JP, Kahn A, Pringault E, Vandewalle A. 1996. Transimmortalized mouse intestinal cells (m-ICc12) that maintain a crypt phenotype. Am J Physiol 270:C1666-C1674.
5. Burns RC, Fairbanks TJ, Sala F, De Langhe S, Mailleux A, Thiery JP, Dickson C, Itoh N, Warburton D, Anderson KD, Bellusci S. 2004. Requirement for fibroblast growth factor 10 or fibroblast growth factor receptor 2-IIIb signaling for cecal development in mouse. Dev Biol 265:61-74.
6. Cohen MM, Jr. 2003. Neoplasms associated with alterations in fibroblast growth factor receptors. Am J Med Genet A 119:97-100.
7. Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM. 1996. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 12:390-397.
8. Davidson D, Blanc A, Filion D, Wang H, Plut P, Pfeffer G, Buschmann MD, Henderson JE. 2005. Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis. J Biol Chem 280:20509-20515.
9. Dignass AU, Sturm A. 2001. Peptide growth factors in the intestine. Eur J Gastroenterol Hepatol 13:763-770.
10. Fairbanks TJ, Sala FG, Kanard R, Curtis JL, Del Moral PM, De Langhe S, Warburton D, Anderson KD, Bellusci S, Burns RC. 2006. The fibroblast growth factor pathway serves a regulatory role in proliferation and apoptosis in the pathogenesis of intestinal atresia. J Pediatr Surg 41:132-136; discussion 132-136.
11. Fu XB, Yang YH, Sun TZ, Chen W, Li JY, Sheng ZY. 2003. Rapid mitogen-activated protein kinase by basic fibroblast growth factor in rat intestine after ischemia/reperfusion injury. World J Gastroenterol 9:1312-1317.
12. Han DS, Li F, Holt L, Connolly K, Hubert M, Miceli R, Okoye Z, Santiago G, Windle K, Wong E, Sartor RB. 2000. Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats. Am J Physiol Gastrointest Liver Physiol 279:G1011-G1022.
13. Houchen CW, George RJ, Sturmoski MA, Cohn SM. 1999. FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury. Am J Physiol 276:G249-G258.
14. Housley RM, Morris CF, Boyle W, Ring B, Biltz R, Tarpley JE, Aukerman SL, Devine PL, Whitehead RH, Pierce GF. 1994. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 94:1764-1777.
15. Hu MC, Qiu WR, Wang YP, Hill D, Ring BD, Scully S, Bolon B, DeRose M, Luethy R, Simonet WS, Arakawa T, Danilenko DM. 1998. FGF-18, a novel member of the fibroblast growth factor family, stimulates hepatic and intestinal proliferation. Mol Cell Biol 18:6063-6074.
16. Hughes SE. 1997. Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J Histochem Cytochem 45:1005-1019.
17. Jackson RA, Kumarasuriyar A, Nurcombe V, Cool SM. 2006. Long-term loading inhibits ERK1/2 phosphorylation and increases FGFR3 expression in MC3T3-E1 osteoblast cells. J Cell Physiol 209:894-904.
18. Jang JH, Shin KH, Park YJ, Lee RJ, McKeehan WL, Park JG. 2000. Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer. Cancer Res 60:4049-4052.
19. Jeffers M, McDonald WF, Chillakuru RA, Yang M, Nakase H, Deegler LL, Sylander ED, Rittman B, Bendele A, Sartor RB, Lichenstein HS. 2002. A novel human fibroblast growth factor treats experimental intestinal inflammation. Gastroenterology 123:1151-1162.
20. Kanai M, Rosenberg I, Podolsky DK. 1997. Cytokine regulation of fibroblast growth factor receptor 3 IIIb in intestinal epithelial cells. Am J Physiol 272:G885-G893.
21. Khan WB, Shui C, Ning S, Knox SJ. 1997. Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor. Radiat Res 148:248-253.
22. Kinkl N, Ruiz J, Vecino E, Frasson M, Sahel J, Hicks D. 2003. Possible involvement of a fibroblast growth factor 9 (FGF9)-FGF receptor-3-mediated pathway in adult pig retinal ganglion cell survival in vitro. Mol Cell Neurosci 23:39-53.
23. Laprise P, Langlois MJ, Boucher MJ, Jobin C, Rivard N. 2004. Down-regulation of MEK/ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells. J Cell Physiol 199:32-39.
24. L'Hote CG, Knowles MA. 2005. Cell responses to FGFR3 signalling: Growth, differentiation and apoptosis. Exp Cell Res 304:417-431.
25. Liu Z, Xu J, Colvin JS, Ornitz DM. 2002. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 16:859-869.
26. Liu AY, Roudier MP, True LD. 2004. Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile. Am J Pathol 165:1543-1556.
27. Mueller KL, Jacques BE, Kelley MW. 2002. Fibroblastgrowth factor signaling regulates pillar cell development in the organ of corti. J Neurosci 22:9368-9377.
28. Pinto D, Clevers H. 2005. Wnt, stem cells and cancer in the intestine. Biol Cell 97:185-196.
29. Potten CS, Booth C, Hargreaves D. 2003. The small intestine as a model for evaluating adult tissue stem cell drug targets. Cell Prolif 36:115-129.
30. Rozenblatt-Rosen O, Mosonego-Ornan E, Sadot E, Madar-Shapiro L, Sheinin Y, Ginsberg D, Yayon A. 2002. Induction of chondrocyte growth arrest by FGF: Transcriptional and cytoskeletal alterations. J Cell Sci 115:553-562.
31. Sala FG, Curtis JL, Veitmaat JM, Del Moral PM, Le LT, Fairbanks TJ, Warburton D, Ford H, Wang K, Burns RC, Bellusci S. 2006. Fibroblast growth factor 10 is required for survival and proliferation but not differentiation of intestinal epithelial progenitor cells during murine colon development. Dev Biol 299:373-385.
32. Sancho E, Batlle E, Clevers H. 2003. Live and let die in the intestinal epithelium. Curr Opin Cell Biol 15:763-770.
33. Simon MA. 2000. Receptor tyrosine kinases: Specific outcomes from general signals. Cell 103:13-15.
34. Stark KL, McMahon JA, McMahon AP. 1991. FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages of the mouse. Development 113:641-651.
35. Steiling H, Werner S. 2003. Fibroblast growth factors: Key players in epithelial morphogenesis, repair and cytoprotection. Curr Opin Biotechnol 14:533-537.
36. Tang Y, Swietlicki EA, Jiang S, Buhman KK, Davidson NO, Burkly LC, Levin MS, Rubin DC. 2006. Increased apoptosis and accelerated epithelial migration following inhibition of hedgehog signaling in adaptive small bowel postresection. Am J Physiol Gastrointest Liver Physiol 290:G1280-G1288.
37. Vidrich A, Buzan JM, Ilo C, Bradley L, Skaar K, Cohn SM. 2004. Fibroblast growth factor receptor-3 is expressed in undifferentiated intestinal epithelial cells during murine crypt morphogenesis. Dev Dyn 230:114-123.
38. Visco V, Belleudi F, Marchese C, Leone L, Aimati L, Cardinali G, Kovacs D, Frati L, Torrisi MR. 2004. Differential response to keratinocyte growth factor receptor and epidermal growth factor receptor ligands of proliferating and differentiating intestinal epithelial cells. J Cell Physiol 200:31-44.